Immediate Pain Relieving Effects of Sinbaro-3 for Low Back Pain

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the immediate pain relieving effects of sinbaro-3 pharmaco-acupuncture in patients with low back pain admitted for inpatient care

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jaseng Hospital of Korean Medicine

Criteria

Inclusion Criteria:

• Patients admitted to a Korean Medicine hospital for low back pain with or without radiculopathy

• Age between 18 and 69

• NRS score of >6 on the day of the intervention

• Voluntary participation with written consent given to study consent form

Exclusion Criteria:

• Diagnosis of serious disease(s) which are possible causes of back pain such as malignancy, vertebral fracture, spinal infection, inflammatory spondylitis, cauda equina compression, etc.

• Prior diagnosis of other chronic disease(s) which could affect effectiveness or interpretation of treatment results such as cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, Alzheimer's disease, epilepsy, etc.

• Progressive neurologic deficit(s) or concurrent severe neurological symptoms

• Unsuitable for or at risk of complications from acupuncture treatment such as patients with clotting disorders, severe diabetes with risk of infection, serious cardiovascular disease, or undergoing anticoagulant treatment, etc.

• Under prescription of corticosteroids, immuno-suppressant drugs, psychiatric medicine, or other medication considered unsuitable for subjects by the researcher

• Experience of gastroenteric complications after taking NSAIDs or currently undergoing treatment for digestive disorders

• During pregnancy or suspected pregnancy

• Subjects considered unsuitable for clinical trial by the researcher